Cancer control in Africa: Which priorities?

The Lancet Oncology

Volumn 14, Issue 4, 2013, Pages 277-279

  Vento, Sandro ^a  

^a UNIVERSITY OF BOTSWANA   (Botswana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HEPATITIS B VACCINE; WART VIRUS VACCINE;

AFRICA SOUTH OF THE SAHARA; BLOOD TRANSFUSION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH SERVICE; HEPATITIS B; HUMAN; INFECTION; LETTER; LIVER CELL CARCINOMA; MEDICAL SPECIALIST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVIX CANCER;

DELIVERY OF HEALTH CARE; HUMANS; NEOPLASMS; PUBLIC HEALTH;

EID: 84875786538     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70022-6     Document Type: Letter

References (10)

1. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010, 11:165-173.
2. Wairagala W Working to improve access to palliative care in Africa. Lancet Oncol 2010, 11:227-228.
3. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
4. Anyanwu SN Temporal trends in breast cancer presentation in the third world. J Exp Clin Cancer Res 2008, 27:17.
5. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366:1784-1793.
6. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010, 102:1557-1567.
7. Morhason-Bello IO, Odedina F, Rebbeck TR, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol 2013, 14:e142-e151.
8. Bow EJ There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy. J Antimicrob Chemother 2013, published online Jan 8. 10.1093/jac/dks512.
9. Tapko JB, Mainuka P, Diarra-Nama AJ Status of blood safety in the WHO African region: report of the 2006 survey 2009, WHO Regional Office for Africa, Brazzaville.
10. Bloch EM, Vermeulen M, Murphy E Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012, 26:164-180.